Z3E-22554-82513
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 933 / CA
- Registered
- 2021-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Dose 2 — Pfizer-BioNTech
-
2021-12-15
Registered in v-safe
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-15
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-22
- 2021-12-29
-
2022-01-05
Survey response — day 21, dose 3MedDRA: Cough, Headache, Oropharyngeal pain — Feeling: PoorFree text: Sore throat Cough HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-03-16
- 2022-06-15
- 2022-12-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | No |
| 2 | 2021-04-22 | Pfizer-BioNTech | No |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Sore throat Cough Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release